Medicine
Epidiolex 100 mg/mL oral solution
Epidiolex 100 mg/mL oral solution is a prescription medicine containing Cannabidiol for oral use, marketed by Jazz Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store EPIDIOLEX in an upright position at 20°C to 25°C (68°F to…
Key facts
- Active ingredient (INN)
- Cannabidiol
- Brand
- Epidiolex
- Strength
- 100 mg/mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 1 bottle
- Marketing authorisation holder
- Jazz Pharmaceuticals
- Manufacturer
- Jazz Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store EPIDIOLEX in an upright position at 20°C to 25°C (68°F to 77°F), excursions are permitted between 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N03AX24 Cannabidiol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 October 2018
- Identifiers
- RxCUI 2058900, 2058906DailyMed set ID 8bf27097-4870-43fb-94f0-f3d0871d1eecNDC 70127-100Application NDA210365
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, glass in 1 carton / 100 mL in 1 bottle, glass | 70127-100-10 | Jazz Pharmaceuticals | 5 October 2018 |
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 70127-100-60 | Jazz Pharmaceuticals | 6 October 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Cannabidiol is a prescription medicine indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older. MedsAcross supplies Cannabidiol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CannabidiolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Epidiolex prescribing information (Jazz Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Epidyolex: European public assessment report (EPAR) · European Medicines Agency
Need Epidiolex 100 mg/mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.